Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Brabec

Showing results (161-170 of 182) with videos related to

Pageof 19
Sort By:
Biomedica Biochimica Acta|January 1, 1991
Phosphoinositide signalling system in red blood cells of patients with hereditary spherocytosisA Strunecká, L Krpejsová, E Kmonícková, et al.
Dalton Transactions (Cambridge, England : 2003)|December 10, 2014
Influence of the binding of reduced NAMI-A to human serum albumin on the pharmacokinetics and biological activityV Novohradský, A Bergamo, M Cocchietto, et al.
Molecular Pharmacology|June 20, 1998
DNA interactions of a novel platinum drug, cis-[PtCl(NH3)2(N7-acyclovir)]+Z Balcarová, J Kaspárková, A Zákovská, et al.
Nucleic Acids Research|January 15, 1996
DNA adducts of antitumor trans-[PtCl2 (E-imino ether)2]V Brabec, O Vrána, O Nováková, et al.
Biochemistry|May 29, 1999
DNA modifications by a novel bifunctional trinuclear platinum phase I anticancer agentV Brabec, J Kaspárková, O Vrána, et al.
Blood|May 15, 1994
Mutations in the pyruvate kinase L gene in patients with hereditary hemolytic anemiaC Lenzner, P Nürnberg, B J Thiele, et al.
Journal of Inorganic Biochemistry|January 8, 2000
Sequence-dependent conformational changes in DNA induced by polynuclear platinum complexesT D McGregor, Z Balcarová, Y Qu, et al.
Molecular Pharmacology|September 1, 1997
DNA modifications by antitumor trans-[PtCl2(E-iminoether)2]R Zaludová, A Zákovská, J Kaspárkova, et al.
Biophysical Chemistry|July 1, 1991
Biophysical studies of the complexes of polyriboguanylic acid with brominated and chlorinated polyribocytidylic acidsE M Kogan, N G Dyatlova, N S Sidorova, et al.
European Journal of Biochemistry|June 1, 1997
DNA interactions of bifunctional dinuclear platinum(II) antitumor agentsR Zaludová, A Zákovská, J Kasparková, et al.
Pageof 19

Showing results (161-170 of 182) with videos related to

Sort By:
Pageof 19
Biomedica Biochimica Acta|January 1, 1991
Phosphoinositide signalling system in red blood cells of patients with hereditary spherocytosisA Strunecká, L Krpejsová, E Kmonícková, et al.
Dalton Transactions (Cambridge, England : 2003)|December 10, 2014
Influence of the binding of reduced NAMI-A to human serum albumin on the pharmacokinetics and biological activityV Novohradský, A Bergamo, M Cocchietto, et al.
Molecular Pharmacology|June 20, 1998
DNA interactions of a novel platinum drug, cis-[PtCl(NH3)2(N7-acyclovir)]+Z Balcarová, J Kaspárková, A Zákovská, et al.
Nucleic Acids Research|January 15, 1996
DNA adducts of antitumor trans-[PtCl2 (E-imino ether)2]V Brabec, O Vrána, O Nováková, et al.
Biochemistry|May 29, 1999
DNA modifications by a novel bifunctional trinuclear platinum phase I anticancer agentV Brabec, J Kaspárková, O Vrána, et al.
Blood|May 15, 1994
Mutations in the pyruvate kinase L gene in patients with hereditary hemolytic anemiaC Lenzner, P Nürnberg, B J Thiele, et al.
Journal of Inorganic Biochemistry|January 8, 2000
Sequence-dependent conformational changes in DNA induced by polynuclear platinum complexesT D McGregor, Z Balcarová, Y Qu, et al.
Molecular Pharmacology|September 1, 1997
DNA modifications by antitumor trans-[PtCl2(E-iminoether)2]R Zaludová, A Zákovská, J Kaspárkova, et al.
Biophysical Chemistry|July 1, 1991
Biophysical studies of the complexes of polyriboguanylic acid with brominated and chlorinated polyribocytidylic acidsE M Kogan, N G Dyatlova, N S Sidorova, et al.
European Journal of Biochemistry|June 1, 1997
DNA interactions of bifunctional dinuclear platinum(II) antitumor agentsR Zaludová, A Zákovská, J Kasparková, et al.
Pageof 19